Publications Early versus delayed or no empagliflozin initiation after hospitalisation for heart failure in the United States: A target trial emulation. Read More
Publications Effects of Empagliflozin on Cardiovascular Outcomes Are Consistent Across Sociodemographic Subgroups: A Real-World Analysis From the EMPRISE Study Read More
Publications Cardiovascular outcomes of empagliflozin-GLP-1RA combination therapy in type 2 diabetes: EMPRISE study Read More
Publications Contemporary Guideline-Directed Medical Therapy for Heart Failure in the United States: The EMPACE Study Read More
Publications Comparative healthcare resource utilization and costs of empagliflozin and GLP-1 receptor agonists in type 2 diabetes Read More
Publications Post-authorisation safety study to assess the risk of urinary tract cancer in people with type 2 diabetes initiating empagliflozin: A multi-country European study Read More
Publications Health Care Utilization and Costs Associated With Empagliflozin in Older Adults With Type 2 Diabetes Read More